Plasma N-Terminal Pro-B-Type Natriuretic Peptide Is Associated with Intrinsic Capacity Decline in an Older Population

被引:24
|
作者
Ma, Lina [1 ]
Zhang, Y. [1 ]
Liu, P. [1 ]
Li, S. [1 ]
Li, Y. [1 ]
Ji, T. [1 ]
Zhang, L. [1 ]
Chhetri, J. K. [2 ]
Li, Y. [1 ]
机构
[1] Capital Med Univ, Natl Res Ctr Geriatr Med, Dept Geriatr, Beijing, Peoples R China
[2] Capital Med Univ, Xuanwu Hosp, Dept Neurol & Neurobiol, Beijing, Peoples R China
来源
JOURNAL OF NUTRITION HEALTH & AGING | 2021年 / 25卷 / 02期
基金
国家重点研发计划;
关键词
Intrinsic capacity; N-terminal pro-B-type natriuretic peptide; older adults; chronic inflammation; FRAILTY; ADULTS; INDEX;
D O I
10.1007/s12603-020-1468-3
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives To determine the association between plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) and intrinsic capacity in an older population. Method We recruited 283 participants aged 60 -/+ 97 years (mean 77.42 +/- 4.08 years). Intrinsic capacity was assessed with the World Health Organization Integrated Care for Older People (ICOPE) screening tool including six domains: cognition, locomotion, vitality, hearing, vision, and psychology. Multimorbidity, polypharmacy, gait speed, physical activity, lifestyles, and chronic inflammation were assessed. We used multivariate logistic regression and the Spearman's correlation to assess the association between plasma NT-proBNP and intrinsic capacity. Results The average intrinsic capacity score was 4.53 +/- 1.34. The percentage of decreased intrinsic capacity was 75.3%. Participants with decreased intrinsic capacity were older, with more cardiovascular and cerebrovascular diseases and polypharmacy, and had lower gait speed and higher C-reactive protein. Plasma NT-proBNP was significantly higher in the decreased intrinsic capacity group (128.0[56.8 -/+ 280.8] pg/mL vs. 72.6[39.7 -/+ 120.0] pg/mL, p<0.001). Multivariate logistic regression analysis revealed that NT-proBNP was the only independent risk factor for decreased intrinsic capacity among multiple covariates (odds ratio=1.005, p=0.038). Elevated NT-proBNP levels were associated with abnormal locomotion, hearing, vision, and psychology domains. Additionally, NT-proBNP levels were inversely correlated with the intrinsic capacity score adjusted for both age and coronary artery disease (r=-0.371, p< 0.001). Conclusion Elevated NT-proBNP levels were associated with decreased intrinsic capacity in older persons, independent of age, multimorbidity, polypharmacy, and chronic inflammation. Further longitudinal studies are required to explore the predictive role of NT-proBNP on declines in intrinsic capacity.
引用
收藏
页码:271 / 277
页数:7
相关论文
共 50 条
  • [31] N-terminal pro-B-type natriuretic peptide levels in systolic heart failure
    Hamdi, I.
    Mahfoudhi, H.
    Ben Mansour, N.
    Mazni, F.
    Dahmani, R.
    Lahidheb, D.
    Fehri, W.
    Haouala, H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 79 - 79
  • [32] Prognostic value of N-Terminal Pro-B-Type Natriuretic Peptide in Takotsubo syndrome
    Thomas Stiermaier
    Francesco Santoro
    Tobias Graf
    Francesca Guastafierro
    Nicola Tarantino
    Luisa De Gennaro
    Pasquale Caldarola
    Matteo Di Biase
    Holger Thiele
    Natale D. Brunetti
    Christian Möller
    Ingo Eitel
    Clinical Research in Cardiology, 2018, 107 : 597 - 606
  • [33] Prognostic value of N-Terminal Pro-B-Type Natriuretic Peptide in Takotsubo syndrome
    Stiermaier, Thomas
    Santoro, Francesco
    Graf, Tobias
    Guastafierro, Francesca
    Tarantino, Nicola
    De Gennaro, Luisa
    Caldarola, Pasquale
    Di Biase, Matteo
    Thiele, Holger
    Brunetti, Natale D.
    Moeller, Christian
    Eitel, Ingo
    CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (07) : 597 - 606
  • [34] Serum N-Terminal Pro-B-Type Natriuretic Peptide Levels Are Associated With Functional Capacity in Patients With Peripheral Arterial Disease
    Fan, Jin
    Jouni, Hayan
    Khaleghi, Mahyar
    Bailey, Kent R.
    Kullo, Iftikhar J.
    ANGIOLOGY, 2012, 63 (06) : 435 - 442
  • [35] High N-Terminal Pro-B-Type Natriuretic Peptide: A Biomarker of Lung Cancer?
    Aujollet, Nathalie
    Meyer, Marjorie
    Cailliod, Romain
    Combier, Fanny
    Coignet, Yann
    Campard, Sebastien
    Facy, Olivier
    Bernard, Alain
    Girard, Claude
    CLINICAL LUNG CANCER, 2010, 11 (05) : 341 - 345
  • [36] N-Terminal Pro-B-Type Natriuretic Peptide Predicts the Burden of Pulmonary Embolism
    Luis Alonso-Martinez, Jose
    Urbieta-Echezarreta, Miren
    Javier Anniccherico-Sanchez, Francisco
    Luisa Abinzano-Guillen, Maria
    Luis Garcia-Sanchotena, Jose
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2009, 337 (02): : 88 - 92
  • [37] N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE IN PATIENTS WITH HYPERTENSIVE HEART DISEASE
    Pejovic, Janko
    Ignjatovic, Svetlana
    Dajak, Marijana
    Majkic-Singh, Nada
    Vucinic, Zarko
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2011, 30 (03) : 244 - 249
  • [38] N-terminal pro-B-type natriuretic peptide and mortality in coronary heart disease
    Pöge, U
    Gerhardt, TM
    Woitas, RP
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (19): : 2025 - 2025
  • [39] Correlation between plasma B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in dyspneic emergency and hospitalized patients
    Bissell, DM
    Burton, JH
    Lau, B
    Marcolini, E
    ANNALS OF EMERGENCY MEDICINE, 2004, 44 (04) : S74 - S75
  • [40] N-Terminal Pro-B-Type Natriuretic Peptide Levels in Parkinson's Disease
    Alves, Mariana
    Caldeira, Daniel
    Reimao, Sofia
    Ferro, Jose M.
    Ferreira, Joaquim J.
    MOVEMENT DISORDERS, 2020, 35 (10) : 1886 - 1887